A potent indolylquinoline alleviates growth of human lung cancer cell tumorspheres

Yu Ling Ni, Chang Hung Hsieh, Seung Hun Kim, Jing Ping Wang, Chun Li Su, Ching Fa Yao, Kang Fang*


研究成果: 雜誌貢獻期刊論文同行評審

2 引文 斯高帕斯(Scopus)


To fight cancer at its roots by targeting cancer stem cells is a promising approach for therapy. Previously, an indolylquinoline derivative, 3-((7-ethyl-1H-indol-3-yl)-methyl)-2-methylquinoline (EMMQ), was reported effectively inhibiting the growth of lung cancer cells through impairment of cellular mitochondria functions. To address more on drug efficiency, the study further exploited if EMMQ can impede the propagation of tumorspheres stemmed from non-small cell lung cancer cells. EMMQ inhibited proliferation of spheroids in culture. In animal models, administration of the drug attenuated the spheroid tumorigenicity. The activated apoptosis alleviated growth of xenograft tumors in immune-deficient mice as established by the enriched tumorspheres. More evidence suggested that the reduced stemness of the spheroid tumors is attributed to apoptotic death. The findings supported that EMMQ is an eligible approach to eradicate the minor but tumorigenic lung cancer tumorspheres.

頁(從 - 到)1235-1245
出版狀態已發佈 - 2017 10月 1

ASJC Scopus subject areas

  • 藥理
  • 藥學科學
  • 臨床生物化學
  • 細胞生物學
  • 生物化學(醫學)
  • 癌症研究


深入研究「A potent indolylquinoline alleviates growth of human lung cancer cell tumorspheres」主題。共同形成了獨特的指紋。